Ignite Creation Date:
2024-05-06 @ 2:21 PM
Last Modification Date:
2024-10-26 @ 1:30 PM
Study NCT ID:
NCT04298567
Status:
COMPLETED
Last Update Posted:
2024-06-28
First Post:
2020-02-19
Brief Title:
Study to Learn More About the Safety and Effectiveness of Rivaroxaban Xarelto When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart CAD andor With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms Symptomatic PAD
Sponsor:
Organization:
Bayer
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
300
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 62656 |
Who Masked List: